Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 3 Unknown 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 390 Carboplatin 344 Gemcitabine 332 pembrolizumab 329 Cisplatin 328 Paclitaxel 297 Radiotherapy 296 Docetaxel 286 Bevacizumab 253 Rituximab 234 Capecitabine 223 Nivolumab 220 Dexamethasone 206 Fluorouracil 190 fludarabine 177 Oxaliplatin 177 Pemetrexed 153 Doxorubicin 153 Irinotecan 148 Leucovorin 144 Etoposide 144 Cytarabine 133 Cetuximab 129 Bortezomib 129 fludarabine phosphate 128 Lenalidomide 126 Erlotinib Hydrochloride 120 Filgrastim 119 Temozolomide 113 Radiosurgery 113

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Niacin × Clear all

NCT00285857 2017-03-09

Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

Stanford University

Phase 2 Terminated

30 enrolled 7 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡